H2O Innovation- Business Overview- HEOFF Stock

 



H20 Innovation Incorporation was founded in 2000 and the company's main office is in Quebec, Canada. Approximately more than 900 employees are working in the company.


H2O Innovation Inc is providing innovative water treatment solutions. The company's water treatment technology is based on membrane filtration. The company operations are based on three categories: 1- Water technologies & Services 2- Speciality products 3- operations and maintenance services.


It is offering the water treatment technology based on membrane filtration to the following businesses
1- Municipal or government sectors.

2- Industrial sector

3- The end-users of natural resources.

4- The services sector


The company is also providing a digital solution for monitoring and optimization of the water treatment system

Following are the products of the company:

1- FiberFlex for water treatment

2- FlexMBR for water treatment.

3- Speciality Chemicals.

4- Consumables products

5- Specialized products

6- Reverse Osmosis Chemicals

7- Resistant equipment for corrosion.

8- Flexible grooved end coupling

9- Fiberglass reinforced polyester

10- Bag Filters

11- Cartridges

12- Strainers

13- Maple products



HEOFF Stock Price



On June 23, 2022, the HEOFF Stock price was 1.39 US dollars. On Feb 5, 2021, the highest HEOFF Stock price was 2.44 US dollars recorded. In the last five years, the company stock price was increasing from Sep 2020 to the end of 2021 and now again in 2022, the company stock price is showing a downward trend. 


The company stock is undervalued, which means selling below the fair value of the stock price. 

The company's earnings are boosting and analysts are expecting a growth in earnings of 51.2% per year. The company's short-term assets are more than the short-term liabilities and long-term liabilities. The company has debt to equity at a satisfactory level.




Comments

Popular posts from this blog

Trillium Gold Mines Inc- Overview

LGIQ Busienss Overview

Interpace Biosciences Completes Its Pharma Services Business Sale to Flagship Biosciences, Inc.